Institutional investors hold a majority ownership of ACT through the 86.59% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2013, these large investors purchased a net $1.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CROSBY ADVISORS LLC Bought 368.3 Thousand shares of Actavis PLC
FIL INVESTMENTS INTERNATIONAL Bought 76.7 Thousand shares of Actavis PLC
AMUNDI SMITH BREEDEN LLC Bought 70.9 Thousand shares of Actavis PLC